Biting the bullet

Biting the bullet

The painful cutbacks being undertaken by Sphinx Pharmaceuticals Inc. are a pointed reminder that penny pinching needs to begin when times are good.

The company's experience provides a cautionary tale for others in the industry. It was a darling of the 1991-92 financing window, raising $75 million in a January

Read the full 529 word article

How to gain access

Continue reading with a
two-week free trial.